Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 14 1002 / https://doi.org/10.3332/ecancer.2020.1002

Case Report

VUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient

Microsatellite instability (MSI) and POLD1 mutations are usually described in colorectal tumours in patients with polyposis syndrome but rarely found in breast tumours. This case describes a metastatic luminal B breast tumour in a young patient with an important family history of cancer. Mutational studies found a Variant of Uncertain Significance (VUS)-type alteration in POLD1 that motivated the study for MSI, which was found positive. Recent data point towards the use of pembrolizumab as a treatment option for tumour presenting with MSI instead of chemotherapy.

Keywords: POLD1, luminal B breast cancer, pembrolizumab, microsatellite instability

Loading Article Metrics ... Please wait

Related articles

Case Report: The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases

Abstract | Full Article | PDF Published: 17 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1011

Case Report: Slowly developing toxic epidermal necrolysis-like reaction associated with pemetrexed and carboplatin

Abstract | Full Article | PDF Published: 13 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1010

Case Report: Multiple malignant transformations of an ovarian mature cystic teratoma

Abstract | Full Article | PDF Published: 04 Feb 2020 / https://doi.org/10.3332/ecancer.2020.1009

Review: Inherited lung cancer: a review

Abstract | Full Article | PDF Published: 27 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1008

Research: Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer

Abstract | Full Article | PDF Published: 27 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1007



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation